Last updated on August 2018

Treatment of Atopic Dermatitis by a Full Body Blue Light Device

Brief description of study

Multicentric, placebocontrolled, doubleblinded, threearmed, prospective, randomized controlled trial.150 patients diagnosed with atopic dermatitis will be randomized to arm 1 (irradiation for 30min at 415nm wavelength), arm 2 (irradiation for 30min at 450nm wavelength), and arm 3 (irradiation for 30min at lowdose (placebo)). Irradiation will be scheduled 3 times a week for 8 weeks. Patients will be followed up for four weeks after the last irradiation.

Clinical Study Identifier: NCT03085303

Contact Investigators or Research Sites near you

Start Over

Michael Schoen, Prof

University Hospital Goettingen
Goettingen, Germany

Wolfgang Pfuetzner, Prof

University Hospital Marburg
Marburg, Germany

Hans-Joachim Laubach, Dr

University Hospital Geneva
Geneva, Switzerland